(1)
Falchi, L.; Baron, J. M.; Orlikowski, C. A.; Ferrajoli, A. BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Mediterr J Hematol Infect Dis 2016, 8, e2016011.